On May 6, 2026, Shenzhen Viqee Technology Co., Ltd. (Viqee Tech), a leading Shenzhen-based high-tech enterprise specializing in innovative cosmetic raw materials, obtained approval for its IPO application at the Beijing Stock Exchange (BSE). The company is expected to become China’s first A-share listed company focused on cosmetic peptide raw materials, setting a new benchmark for the capitalization development of Shenzhen’s beauty raw material industry.
Founded in 2011, Viqee Tech is an innovation-driven high-tech enterprise headquartered in Shenzhen. It focuses on the R&D, production, and sales of skin-active peptides and characteristic plant extracts, while also providing ODM services for finished cosmetic products, building a complete supply chain capability from raw material innovation to finished product delivery. Leveraging its self-developed core peptide technology, the company’s products cover core efficacy tracks such as anti-aging, repair, and brightening, breaking the monopoly of foreign raw materials and successfully entering the supply chains of top domestic and international beauty brands.
In terms of customer portfolio, Viqee Tech has established cooperation with global beauty giants such as Procter & Gamble (P&G) and Unilever, as well as leading domestic brands including Marubi and Furerjia. Notably, the core active ingredient “Caffeoyl Hexapeptide-9” in P&G’s star product OLAY Anti-Aging Firming Cream is an innovative raw material independently developed by Viqee Tech. It is the first Chinese original raw material used as the main active ingredient in a core product by an international top beauty brand, demonstrating the company’s world-class R&D strength.
The company has delivered strong financial performance. From 2023 to 2025 (the reporting period), its operating revenue reached 165 million yuan, 248 million yuan, and 275 million yuan respectively, while net profit rose to 42.29 million yuan, 70.64 million yuan, and 90.85 million yuan. The compound annual growth rate of net profit exceeded 40% over the three years, securing its position as a top player in China’s peptide raw material sector. The growth momentum continued into Q1 2026, with projected operating revenue of approximately 66.42 million yuan (up 2.71% year-on-year) and net profit of 24.34 million yuan (up 4.37% year-on-year).
For this IPO, Viqee Tech plans to raise 200 million yuan. The funds will be allocated to two core projects: 170 million yuan for the construction of the Zhuhai Viqee Health Industrial Park to expand production capacity for peptide raw materials and finished products; 30 million yuan for the upgrade of the R&D center to strengthen research in cutting-edge fields such as active peptides and new plant raw materials, consolidating its technological barriers. Industry analysts believe that the fundraising will help the company overcome capacity constraints, enhance innovation capabilities, and further increase its global market share.
As a leader in China’s peptide raw material segment, Viqee Tech’s successful IPO approval reflects the capital market’s high recognition of its technological strength, performance growth, and industry status. It also marks a significant milestone in Shenzhen’s beauty raw material industry’s transformation from “OEM manufacturing” to “innovation-driven R&D”. With the rise of domestic beauty brands and the expansion of the global efficacy skincare market, Viqee Tech, supported by its core technology and high-quality customer resources, is poised to leverage capital to lead the high-quality development of China’s cosmetic raw material industry and build a globally influential Chinese beauty raw material brand.
aitike